Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Albireo's A3309 meets constipation endpoint

October 12, 2010 11:57 PM UTC

Albireo (Gothenburg, Sweden) said 10 and 15 mg once-daily oral A3309 for eight weeks met the primary endpoint in a Phase IIb trial to treat chronic idiopathic constipation. A3309 significantly increas...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article